Cara Therapeutics (CARA) PT Raised to $33 at Jefferies
Tweet
Share
E-mailGet Alerts CARA Hot Sheet
Price: $5.32 --0%
Rating Summary:
6 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Rating Summary:
6 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Join SI Premium – FREE
Jefferies analyst Chris Howerton raised the price target on Cara Therapeutics (NASDAQ: CARA) to $33.00 (from $25.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aebi Schmidt Holding AG (AEBI) PT Raised to $17 at DA Davidson Following Q2 Results
- Johnson Rice Upgrades Magnolia Oil & Gas Corp. (MGY) to Accumulate
- Recursion Pharmaceuticals (RXRX) PT Lowered to $5.30 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
